Medical Treatment for Endometriosis

Merve Konal
In: Obstetrics and Gynecology · 2024 · doi:10.5772/intechopen.1007680 · W4404042676
book-chapter OA: hybrid CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This review covers hormonal, non-hormonal, emerging, and experimental medical treatments for endometriosis, alongside lifestyle modifications, detailing mechanisms, efficacy, side effects, and comparative outcomes for comprehensive patient management.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-06 ⓘ

This chapter reviews medical treatments for endometriosis, focusing on hormonal therapies (including oral contraceptives, GnRH agonists/antagonists, progestins/SPRMs, and aromatase inhibitors) and non-hormonal approaches such as pain management, while also describing emerging experimental directions like immunomodulatory drugs, gene therapy, and stem cell therapy. It compares key mechanisms, reported efficacy for pain and lesion-related outcomes, and common side effects, noting that GnRH therapies reduce estrogen-driven lesion activity but are limited by hypoestrogenic effects such as menopausal symptoms and bone density loss. A stated limitation is that treatment discussions rely on a broad overview rather than a single unified trial, and many options involve tradeoffs that can necessitate short-term use or adjunct add-back therapy. This paper is centrally about endometriosis — it provides an overview and comparison of medical treatment classes and their efficacy and side effects.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis is a chronic gynecological condition characterized by the presence of endometrial-like tissue outside the uterus, leading to pain, inflammation, and infertility. This chapter provides a comprehensive overview of the medical treatments for endometriosis, emphasizing hormonal and non-hormonal therapies, emerging and experimental treatments, and lifestyle modifications. Hormonal treatments such as oral contraceptives, GnRH agonists and antagonists, progestins, and aromatase inhibitors are explored in detail, highlighting their mechanisms of action, efficacy, and side effects. Non-hormonal treatments, including pain management strategies and complementary therapies, are discussed for their role in alleviating symptoms and improving quality of life. The chapter also delves into novel therapeutic approaches like immunomodulatory drugs, gene therapy, and stem cell therapy, which hold promise for more effective and personalized management of endometriosis. Comparative effectiveness research and patient outcomes are analyzed to provide insights into the most effective treatment strategies. Finally, the importance of integrating lifestyle modifications and patient education into a comprehensive treatment plan is underscored to enhance long-term management and quality of life for endometriosis patients.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK